Deep Genomics has over 100 team members, with expertise in artificial intelligence, automation, cell and molecular biology, clinical development, in vitro disease models, machine learning, medicine, molecular genetics, preclinical development, organic chemistry, and software engineering.
Brendan Frey, Ph.D.
Founder and Chief Executive Officer
Chief Scientific Officer
Chief Financial Officer
Amit Deshwar, Ph.D.
Senior Vice President and Head of Platform
Vice President of People Operations
Vice President and Head of Research Operations
Head of Software and Data Engineering
Strategic Advisory Board
Jennifer Cook, M.B.A., M.S.
Strategic Advisor and Special Advisor to the CEO; Board Member, BridgeBio; CEO, Grail; Senior Management, Genentech & Roche
Peter Barton Hutt, L.L.B., L.L.M
Senior Counsel, Covington & Burling, LLP
Steve Jurvetson, M.S.E.E., M.B.A.
Co-Founder, Future Ventures Board Member, SpaceX, Tesla
Vinod Khosla, M.S., M.B.A.
Founder, Khosla Ventures; Co-Founder, Sun Microsystems
Vern Norviel, M.S., J.D.
Partner, Wilson Sonsini Goodrich and Rosati; Adjunct Professor, UC Berkeley
Tal Zaks, M.D., Ph.D.
Venture Partner, Orbimed; Previously Chief Medical Officer at Moderna; Board Member Adaptimmune Therapeutics and Teva Pharmaceutical Industries
Scientific Advisory Board
Art Krieg, M.D.
Former CEO/CSO, Checkmate Pharmaceuticals and Former President, Oligonucleotide Therapeutic Society
Mark Edbrooke, Ph.D.
Former AstraZeneca, GlaxoSmithKline
Masad Damha, Ph.D.
Distinguished James McGill Professor of Chemistry, McGill University
Steven Dowdy, Ph.D.
Professor, University of California San Diego School of Medicine
Yann LeCun Ph.D.
Chief AI Scientist, Facebook; Professor, New York University
Benjamin Neale, Ph.D.
Associate Professor in the Analytic and Translational Genetics Unit, Massachusetts General Hospital
Board of Directors
Brendan Frey, Ph.D.
William D. “Chip” Baird, M.B.A.
Lead Independent Director
Maryanna Saenko, M.S.
Matt Cahill, J.D., Ph.D., M.B.A.
Nessan Bermingham, Ph.D.
Jacqueline Fok, Ph.D.
Dion Madsen, C.F.A.
Deep Genomics has offices in Toronto and Boston. The AI platform and preclinical research teams are located in the heart of Toronto, the fastest growing tech hub in North America and widely recognized as one of the most livable cities in the world. The facilities are located in the MaRS Discovery District, right beside the University of Toronto, four research hospitals, three medical research institutes, and the AI research labs of Google, Uber and the Vector Institute for Artificial Intelligence. The clinical development and business development teams are led out of Boston.